Latest Insider Transactions at Interpace Biosciences, Inc. (IDXG)
This section provides a real-time view of insider transactions for Interpace Biosciences, Inc. (IDXG). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of INTERPACE BIOSCIENCES, INC. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of INTERPACE BIOSCIENCES, INC.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Feb 01
2024
|
Christopher Mc Carthy Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
10,000
+17.97%
|
-
|
|
Jul 31
2023
|
Christopher Mc Carthy Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
25,000
+41.22%
|
-
|
|
May 21
2021
|
Thomas W. Burnell President & CEO |
BUY
Open market or private purchase
|
Indirect |
10,855
+50.0%
|
$86,840
$8.68 P/Share
|
|
Mar 10
2021
|
Thomas John Freeburg Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+49.02%
|
-
|
|
Mar 01
2021
|
Peter Kamin > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
25,840
+5.92%
|
$77,520
$3.08 P/Share
|
|
Mar 01
2021
|
Peter Kamin > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
16,360
+5.71%
|
$49,080
$3.08 P/Share
|
|
Feb 26
2021
|
Peter Kamin > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
26,104
+6.35%
|
$78,312
$3.17 P/Share
|
|
Feb 26
2021
|
Peter Kamin > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
14,946
+5.56%
|
$44,838
$3.17 P/Share
|
|
Jan 29
2021
|
Robert J. Gorman Director |
BUY
Grant, award, or other acquisition
|
Direct |
12,438
+39.87%
|
$49,752
$4.02 P/Share
|
|
Dec 01
2020
|
Thomas W. Burnell President & CEO |
BUY
Grant, award, or other acquisition
|
Direct |
225,000
+33.24%
|
-
|